HOME >> BIOLOGY >> NEWS
Salamanders suffer delayed effects of common herbicide

razine exposure paled in comparison to the persistent effects of atrazine that continued to cause mortality after exposure ceased, said researchers. Compared to salamanders not exposed to atrazine, survivors of the atrazine exposure had significantly lower survival 421 days after being exposed. In other words, effects of early exposure to the chemical were showing up over the long term, such that the net effect of atrazine exposure was even worse later in life than it was while the animals were being exposed.

"The biggest surprise was that it took nearly a year to detect the effects of atrazine at 4 parts per billion, which is just 1 part per billion above the maximum allowable level in drinking water set by the U.S Environmental Protection Agency," said Rohr, who presented his findings at a recent workshop organized by the U.S Geological Survey in St. Louis, Missouri.

"What this tells me is that we need to consider the long-term effects of chemicals, and that exposure to atrazine during formative stages might have permanent effects on these salamanders that increases their risk of mortality," he added.

While the mechanism by which atrazine causes elevated mortality remains unclear, Rohr says other scientists have evidence suggesting that this pesticide is an endocrine disruptor.

Such chemicals disrupt the production of hormones that are vital to normal bodily functions. Concentrations of atrazine as low as 0.1 parts per billion have been shown to cause male frogs to develop both male and female organs by altering their production of sex hormones.

Findings from Rohr's study, which was funded by the U.S Environmental Protection Agency, National Science Foundation, and the Kentucky Academy of Sciences, could have implications for global amphibian declines.

"Salamanders, and amphibians in general, are crucial to ecosystems, as both predators and prey. They can be seen as bioindicators of environmental stress and harbingers of risk
'"/>

Contact: Amitabh Avasthi
axa47@psu.edu
814-865-9481
Penn State
23-Mar-2007


Page: 1 2 3

Related biology news :

1. Better sleep may put Huntingtons disease sufferers back on track
2. Male or female factor infertility -- men suffer just the same
3. New treatment increases life time expectancy of patients suffering from advanced liver cancer
4. Coarse particulate matter in air may harm hearts of asthma sufferers, UNC study finds
5. Vaccine hope for sufferers of potentially fatal stomach bug
6. Swell gel could bring relief to back pain sufferers
7. How fish species suffer as a result of warmer waters
8. Wolves are suffering less from inbreeding than expected
9. Hope remains for Alzheimers sufferers
10. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
11. Children of allergy sufferers prone to same problem

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading provider ... new solution aimed at combatting fraud, waste and abuse ... introduced at the Action on Disaster Relief conference in ... point for UN agencies and foreign assistance organizations throughout ... waste and abuse are a largely unacknowledged problem in ...
(Date:1/25/2017)... The Elements of Enterprise Information Security ... of a comprehensive set of business processes and ... identities and providing a secured and documented access ... number of programs opted by enterprises to maintain ... processes and changing policies. However, there are some ...
(Date:1/24/2017)... 24, 2017  It sounds simple and harmless—an ... monitors vital signs and alerts parents on their ... saturation level drops. But pediatric experts argue that ... with no evidence of medical benefits, especially to ... aggressively to parents of healthy babies, promising peace ...
Breaking Biology News(10 mins):
(Date:2/16/2017)...   Capricor Therapeutics, Inc. (NASDAQ: ... first-in-class biological therapies for cardiac and other medical ... terminate its license agreement with the Mayo Clinic ... "Our decision to return these rights ... efforts to advance our core cell and exosome-based ...
(Date:2/16/2017)...  Champions Oncology, Inc. (NASDAQ: CSBR ), ... advanced technology solutions and products to personalize the development ... of new cohorts of PDX models to their existing ... Champions, product line in hepatocellular cancer, breast cancer, castrate ... non-small cell lung cancer (including EGFR mutation; ALK/ROS1 positive) ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... extended its industry leading Biochemistry Services specifically targeting the rapidly growing needs ... methods for the biochemical and biosimilar characterization , product-related impurity characterization, ...
(Date:2/15/2017)... Inc. (Vanda) (NASDAQ: VNDA), today announced financial and ... year ended December 31, 2016. "2016 ... continued to demonstrate strong growth in our commercial ... Mihael H. Polymeropoulos, M.D., Vanda,s President and CEO. ... milestones underscores Vanda,s commitment to bringing important new ...
Breaking Biology Technology:
Cached News: